In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Dutch Queen promotes biobased building materials
In the Netherlands, Dutch Queen consort Máxima visited two Uden worksites promoting biobased building materials made from Netherlands fiber crops.
The March 26 visit...
ReefCircular launches crowdfunding campaign for shell bioconcrete
In Denmark, ReefCircular, a company developing a shell-based bioconcrete to help restore marine habitats, has launched a crowdfunding campaign on Kickstarter.
The company’s bioconcrete...
Aleph Farms raises $29 million for lab-grown steak
In Israel, cultivated meat producer Aleph Farms has raised $29 million to expand production at its Rehovot pilot plant and expand production into Europe...